P53, N- and K-Ras, and β-Catenin Gene Mutations and Prognostic Factors in Nasal NK/T-Cell Lymphoma from Hokkaido, Japan

Human Pathology

Volumn 35, Issue 1, 2004, Pages 86-95

  Takahara, Miki ^a   Kishibe, Kan ^a   Bandoh, Nobuyuki ^a   Nonaka, Satoshi ^a   Harabuchi, Yasuaki ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Epstein Barr virus encoded small nuclear region type 1; LDH; Epstein Barr virus; LMP1; Guanosine 5 diphosphate; GTP; Guanosine 5 triphosphate; LCM; Lactate dehydrogenase; GDP; Latent membrane protein type 1; EBER 1; Natural killer; EBV; NK

Indexed keywords

BETA CATENIN; CD20 ANTIGEN; CD56 ANTIGEN; K RAS PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; JAPAN; MALE; MISSENSE MUTATION; NONSENSE MUTATION; NOSE CAVITY CANCER; ONCOGENE K RAS; ONCOGENE N RAS; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE;

EID: 1642539989     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2003.08.025     Document Type: Article

References (36)

1. Harabuchi Y, Imai S, Wakashima J, et al: Nasal T-cell lymphoma causally associated with Epstein-Barr virus: Clinicopathologic, phenotypic, and genotypic studies. Cancer 77:2137-2149, 1996
2. Yamanaka N, Harabuchi Y, Sambe S, et al: Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Cancer 56:768-776, 1985
3. Nakamura S, Katoh E, Koshikawa T, et al: Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese. Pathol Int 47:38-53, 1997
4. Eichel BS, Harrison EG, Devine KD, et al: Primary lymphoma of the nose including a relationship to lethal midline granuloma. Am J Surg 112:597-605, 1966
5. Nagata H, Konno A, Kimura N, et al: Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus. Blood 97:708-713, 2001
6. Harabuchi Y, Yamanaka N, Kataura A, et al: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335:128-130, 1990
7. Minarovits J, Hu LF, Imai S, et al: Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. J Gen Virol 75:77-84, 1994
8. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 351:453-456, 1991
9. Quintanilla-Martinez L, Franklin JL, Guerrero I, et al: Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: High prevalence of p53 overexpression. HUM PATHOL 30:849-855, 1999
10. Li T, Hongyo T, Syaifudin M, et al: Mutations of the p53 gene in nasal NK/T-cell lymphoma. Lab Invest 80:493-499, 2000
11. Quintanilla-Martinez L, Kremer M, Keller G, et al: p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: Association with large cell morphology and advanced disease. Am J Pathol 159:2095-2105, 2001
12. Lowy DR, Willumsen BM: Function and regulation of ras. Annu Rev Biochem 62:851-891, 1993
13. Neri A, Knowles DM, Greco A, et al: Analysis of RAS oncogene mutations in human lymphoid malignancies. Proc Natl Acad Sci USA 85:9268-9272, 1988
14. Takakuwa T, Hongyo T, Syaifudin M, et al: Microsatellite instability and k-ras, p53 mutations in thyroid lymphoma. Jpn J Cancer Res 91:280-286, 2000
15. Ballerini P, Gaidano G, Gong JZ, et al: Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 81:166-176, 1993
16. Aberle H, Butz S, Stappert J, et al: Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J Cell Sci 107: 3655-3663, 1994
17. He TC, Sparks AB, Rago C, et al: Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512, 1998
18. Sparks AB, Morin PJ, Vogelstein B, et al: Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130-1134, 1998
19. Garcia-Rostan G, Tallini G, Herrero A, et al: Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res 59:1811-1815, 1999
20. Koch A, Denkhaus D, Albrecht S, et al: Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res 59:269-273, 1999
21. Nakatsuka Si S, Hongyo T, Syaifudin M, et al: Mutations of p53, c-kit, K-ras, and beta-catenin gene in non-Hodgkin's lymphoma of adrenal gland. Jpn J Cancer Res 93:267-274, 2002
22. Hoshida Y, Hongyo T, Nakatsuka S, et al: Gene mutations in lymphoproliferative disorders of T and NK/T cell phenotypes developing in renal transplant patients. Lab Invest 82:257-264, 2002
23. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
24. Bandoh N, Hayashi T, Kishibe K, et al: Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma. Cancer 94:1968-1980, 2002
25. Martinez-Delgado B, Robledo M, Arranz E, et al: Correlation between mutations in p53 gene and protein expression in human lymphomas. Am J Hematol 55:1-8, 1997
26. Park WS, Oh RR, Park JY, et al: Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol 193:483-490, 2001
27. Harabuchi Y, Tsubota H, Ohguro S, et al: Prognostic factors and treatment outcome in non-Hodgkin's lymphoma of Waldeyer's ring. Acta Oncol 36:413-420, 1997
28. Jaffe ES, Chan JK, Su IJ, et al: Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 20:103-111, 1996
29. Gulley ML, Burton MP, Allred DC, et al: Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma. HUM PATHOL 29:252-259, 1998
30. Zhang Q, Gutsch D, Kenney S: Functional and physical interaction between p53 and BZLF1: Implications for Epstein-Barr virus latency. Mol Cell Biol 14:1929-1938, 1994
31. Chen W, Cooper NR: Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity. J Virol 70:4849-4853, 1996
32. Kojya S, Matsumura J, Ting L, et al: Familial nasal NK/T-cell lymphoma and pesticide use. Am J Hematol 66:145-147, 2001
33. Elenitoba-Johnson KS, Medeiros LJ, Khorsand J, et al: P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease. Am J Clin Pathol 106:728-738, 1996
34. Hu LF, Minarovits J, Cao SL, et al: Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5′-flanking region. J Virol 65:1558-1567, 1991
35. Ko YH, Ree HJ, Kim WS, et al: Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans. Cancer 89: 2106-2116, 2000
36. Aviles A, Diaz NR, Neri N, et al: Angiocentric nasal T/natural killer cell lymphoma: A single centre study of prognostic factors in 108 patients. Clin Lab Haematol 22:215-220, 2000